Saturday, July 4, 2026

The New Axis of Trouble? Beijing, Moscow Allies Join Kim Jong Un’s Power Show

North Korea celebrated the Workers' Party's 80th anniversary at May Day Stadium, with uncertainty about a military parade.

Ebola Outbreak in DR Congo: Why Contact Tracing is Stalling at 45%?

The Ebola contact tracing rate in DR Congo has dropped to 45%, raising alarms for outbreak control as cases surge rapidly.

North Korea Says ‘We Don’t Care’ About U.S. Entry Ban List

North Korea rejects U.S. entry ban exclusion, stating it shows no interest in dialogue and will not welcome Americans in the future.

Tag: Phase 1 trials

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Top News

- Our Sponsors Ad -

Follow us